Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Researchers at Cima Universidad De Navarra Publish a Study Evaluating the Antitumor Activity of Ras Inhibitors in Cholangiocarcinoma

Summary by diariodenavarra.es
Researchers at Cima Universidad de Navarra, in collaboration with Revolution Medicines, have published a study that first evaluates the antitumor activity of RAS inhibitors in cholangiocarcinoma, a type of bile duct cancer with very poor prognosis for its patients. Read more]]>

1 Articles

diariodenavarra.esdiariodenavarra.es
Center

Researchers at Cima Universidad De Navarra Publish a Study Evaluating the Antitumor Activity of Ras Inhibitors in Cholangiocarcinoma

Researchers at Cima Universidad de Navarra, in collaboration with Revolution Medicines, have published a study that first evaluates the antitumor activity of RAS inhibitors in cholangiocarcinoma, a type of bile duct cancer with very poor prognosis for its patients. Read more]]>

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

diariodenavarra.es broke the news on Thursday, April 23, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Cholangiocarcinoma icon

Cholangiocarcinoma

Pamplona icon

Pamplona

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal